Erste Asset Management Gmb H Janux Therapeutics, Inc. Put Options Transaction History
Erste Asset Management Gmb H
- $7.79 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding JANX
# of Institutions
195Shares Held
57.3MCall Options Held
626KPut Options Held
155K-
Ra Capital Management, L.P. Boston, MA11.2MShares$260 Million6.27% of portfolio
-
Janus Henderson Group PLC London, X04.6MShares$107 Million0.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.65MShares$85 Million0.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.33MShares$77.5 Million4.61% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$54.5 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $969M
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...